Masakatsu Hishizawa
Overview
Explore the profile of Masakatsu Hishizawa including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
87
Citations
1644
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nakamura N, Kanda J, Kondo T, Kitano T, Ikeda T, Imada K, et al.
Cytotherapy
. 2024 Dec;
27(3):307-315.
PMID: 39652019
Background Aims: Methotrexate (MTX) is used as standard graft-versus-host disease (GVHD) prophylaxis in allogeneic hematopoietic stem cell transplantation. However, the optimal dosing regimen among the various MTX regimens available remains...
2.
Nakamura M, Chonabayashi K, Narita M, Matsumura Y, Nishikawa M, Ochi Y, et al.
Br J Haematol
. 2024 Aug;
205(4):1430-1443.
PMID: 39187468
Structural variations involving enhancer hijacking induce aberrant oncogene expression and cause tumorigenesis. A rare translocation, t(3;8)(q26.2;q24), is associated with MECOM and MYC rearrangement, causing myeloid neoplasms with a dismal prognosis....
3.
Wada F, Kanda J, Kamijo K, Nishikubo M, Yoshioka S, Ishikawa T, et al.
Cell Transplant
. 2023 Aug;
32:9636897231194497.
PMID: 37646153
Haploidentical-related donor transplantation using posttransplant cyclophosphamide (PTCy-haplo) and cord blood transplantation (CBT) are valid alternatives for patients with hematological malignancies when HLA-matched donor transplantation (MDT) is unavailable. However, the effects...
4.
Morita-Fujita M, Shindo T, Iemura T, Arai Y, Kanda J, Okada K, et al.
Transplant Cell Ther
. 2023 Mar;
29(6):347.e1-347.e11.
PMID: 36889508
Cord blood transplantation (CBT) is an attractive therapeutic option for patients with hematologic malignancies. CBT tolerates HLA mismatches between donors and recipients, but the HLA mismatches that generate graft-versus-tumor (GVT)...
5.
Kishimoto W, Fujita K, Shimazu Y, Hamada T, Miyamoto T, Yasumi T, et al.
Rinsho Ketsueki
. 2023 Jan;
63(12):1633-1638.
PMID: 36653135
A 54-year-old woman was referred to our hospital for pancytopenia and liver dysfunction, and with no personal or family history of hemophagocytic lymphohistiocytosis (HLH). Although the etiology was unknown, she...
6.
Sugimoto N, Kanda J, Nakamura S, Kitano T, Hishizawa M, Kondo T, et al.
Blood
. 2022 Sep;
140(22):2398-2402.
PMID: 36112961
No abstract available.
7.
Otsuka Y, Nishikori M, Fujimoto M, Nakao K, Hishizawa M, Haga H, et al.
EJHaem
. 2022 Jul;
1(1):323-327.
PMID: 35847735
Intraclonal diversity is commonly observed in patients with follicular lymphoma (FL), whereas tumor cells at the onset and relapse usually share early genetic events such as VDJ rearrangement of the...
8.
Morimoto S, Shindo T, Iga Y, Morita M, Yurugi K, Masuda K, et al.
Rinsho Ketsueki
. 2022 Jan;
62(12):1678-1683.
PMID: 35022336
In this study, we report a case of a 77-year-old woman who was presented with anemia in the winter of 2002. She was diagnosed with cold agglutinin disease (CAD) and...
9.
Wada F, Kanda J, Yoshioka S, Ishikawa T, Akasaka T, Ueda Y, et al.
Transplantation
. 2021 Dec;
106(6):1279-1287.
PMID: 34935764
Background: Unrelated cord blood (UCB) and haploidentical related donor transplantation using posttransplant cyclophosphamide (PTCy-haplo) have become alternative options to treat patients with hematological malignancies without a HLA-matched donor. Methods: We...
10.
Shimizu T, Kondo T, Nannya Y, Watanabe M, Kitawaki T, Shindo T, et al.
J Cell Mol Med
. 2021 Jun;
25(14):7095-7099.
PMID: 34132463
Acute basophilic leukaemia (ABL) is a rare subtype of acute myeloid leukaemia (AML); therefore, few data are available about its biology. Herein, we analysed two ABL patients using flow cytometry...